Tirzepatide, the novel medication, is creating considerable buzz within the medical community. It functions differently from common diabetes therapies , targeting multiple receptors involved in sugar regulation and hunger . Initial research have demonstrated significant efficacy in controlling blood sugar in individuals with diabetes of the second